Windlas Biotech Ltd Share Price
As on 19 November 2025 at 01:26 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-10.57%
Over 6 Months
-12.42%
Over 1 Year
-15.74%
Over 3 Years
241.80%
Windlas Biotech Ltd Summary
Close ₹829.20
Open ₹822
High ₹855.55
Low ₹820.80
Volume 60,710
Net Turnover (in Cr) ₹5.06
52Wk High ₹1,178.85
52Wk Low ₹665.10
52Wk High / Low
665.10
1,178.85
Windlas Biotech Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹1,747.72
EPS (TTM) 31.78
Book Value (BV) 253.42
Div. Yield 0.70 %
P/E (TTM) 26.06
Price/Book Value 3.27
Delivery % 54.50 %
Face Value 5
Key Ratios
PE Ratio 35.98
PB Ratio 4.31
EV to Sales 2.89
PEG Ratio 10.27
ROA 11.20
ROE 12.69
Debt-Equity 0.04
Net Profit Margin 7.98
Operating Profit Margin 14.71
Windlas Biotech Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 777.90 | 644.42 | 523.05 | 472.64 | 430.69 |
| Total Expenses | 698.14 | 567.33 | 466.01 | 427.07 | 387.17 |
| Profit Before Tax | 79.76 | 77.09 | 57.04 | 45.56 | 21.74 |
| Profit After Tax | 60.99 | 58.19 | 42.63 | 38.09 | 15.57 |
| Operating Profit After Depreciation | 84.14 | 78.20 | 57.83 | 46.98 | 44.82 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 225.50 | 179.05 | 110.38 | 91.62 | 95.94 |
| Total Non Current Assets | 235.32 | 194.92 | 175.44 | 109.36 | 101.81 |
| Total Current Assets | 525.13 | 431.29 | 353.54 | 381.65 | 194.31 |
| Total Assets | 760.45 | 626.21 | 528.98 | 491.01 | 296.12 |
| Total Shareholder's Fund | 505.77 | 449.94 | 402.27 | 394.78 | 199.12 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 68.19 | 108.96 | 60.97 | 9.13 | 11.46 |
| Net Cash Used In Investing Activities | -74.06 | -92.07 | -14.11 | -154.58 | -20.20 |
| Net Cash Used In Financing Activities | 1.01 | -15.29 | -43.74 | 130.09 | 0.78 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 777.52 | 644.42 | 523.05 | 472.64 | 430.70 |
| Total Expenses | 698.13 | 567.40 | 465.99 | 426.60 | 387.17 |
| Profit Before Tax | 79.39 | 77.02 | 57.06 | 46.04 | 11.18 |
| Profit After Tax | 60.65 | 58.14 | 42.64 | 38.56 | 5.01 |
| Operating Profit After Depreciation | 83.78 | 78.13 | 57.84 | 47.45 | 44.82 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 225.50 | 179.05 | 110.38 | 91.62 | 95.94 |
| Total Non Current Assets | 235.32 | 194.92 | 175.47 | 109.39 | 101.85 |
| Total Current Assets | 525.13 | 431.24 | 353.54 | 381.63 | 194.15 |
| Total Assets | 760.45 | 626.16 | 529.01 | 491.03 | 295.99 |
| Total Shareholder's Fund | 505.79 | 450.29 | 402.67 | 395.13 | 198.99 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 68.23 | 108.91 | 60.98 | 9 | 11.45 |
| Net Cash Used In Investing Activities | -74.06 | -92.07 | -14.11 | -154.31 | -20.19 |
| Net Cash Used In Financing Activities | 1.01 | -15.29 | -43.74 | 130.09 | 0.78 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 222.40 | 210.09 | 202.71 | 195.02 | 187 |
| Total Expenses | 193.84 | 183.56 | 177.15 | 170.39 | 163.95 |
| Profit Before Tax | 23.59 | 23.26 | 20.83 | 20.34 | 20.29 |
| Profit After Tax | 17.80 | 17.66 | 16.28 | 15.58 | 15.66 |
| Operating Profit after Depreciation | 32.21 | 31.77 | 30.50 | 28.74 | 27.89 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 222.40 | 210.09 | 202.71 | 195.02 | 187 |
| Total Expenses | 193.84 | 183.56 | 177.15 | 170.38 | 163.95 |
| Profit Before Tax | 23.59 | 23.26 | 20.83 | 19.97 | 20.29 |
| Profit After Tax | 17.80 | 17.67 | 16.29 | 15.23 | 15.66 |
| Operating Profit after Depreciation | 32.21 | 31.77 | 30.50 | 28.37 | 27.89 |
Windlas Biotech Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 814.82
S2 800.43
S3 780.07
Pivot 835.18
R1 849.57
R2 869.93
R3 884.32
Moving Average
20 SMA 905.37
50 SMA 931.50
100 SMA 942.76
200 SMA 938.64
Windlas Biotech Ltd Corporate Actions
Windlas Biotech Ltd
₹5.8/Share
Announcement Date 21 Jul 2025
Record Date 21 Jul 2025
Div Yield 116%
Windlas Biotech Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
Windlas Biotech Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| UTI-Healthcare Fund | 1.35% |
| ICICI Pru P.H.D Fund | 1.26% |
| ICICI Pru Smallcap Fund | 0.29% |
| Bandhan BSE Healthcare Index Fund | 0.06% |
| Bandhan Small Cap Fund | 0.04% |
Windlas Biotech Ltd News
Windlas Biotech to announce Quarterly Result
On 6 November 2025
29 Oct 2025, 05:09 pm
Windlas Biotech to announce Quarterly Result
On 12 August 2025
07 Aug 2025, 02:04 pm
Windlas Biotech to convene AGM
On 28 July 2025
04 Jul 2025, 04:39 pm
Windlas Biotech Ltd Spurts 3.25%
Windlas Biotech Ltd has lost 1.81% over last one month compared to 2.49% gain in BSE Healthcare index and 0.27% rise in the SENSEX
19 Jun 2025, 09:30 am
Windlas Biotech Ltd Slips 4.88%, BSE Healthcare index Shed 1.03%
Windlas Biotech Ltd has lost 9.89% over last one month compared to 1.44% fall in BSE Healthcare index and 1.1% rise in the SENSEX
23 May 2025, 09:30 am
Windlas Biotech Ltd Stock Analysis
- Annual revenue for Windlas Biotech Ltd increased by 20.65% to ₹777.52 crore in FY 2025 from ₹644.42 crore in FY 2024.
- Annual Net Profit for Windlas Biotech Ltd increased by 4.31% to ₹60.65 crore in FY 2025 from ₹58.14 crore in FY 2024.
- Promoter Shareholding in Windlas Biotech Ltd remains unchanged by 0.00% in the most recent quarter, from 62.34% in March 2025 to 62.34% in June 2025.
- Windlas Biotech Ltd delivered a 1-year return of -15.74% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
- Windlas Biotech Ltd share price moved down by 1.57% from its previous close of INR ₹829.20. The latest Windlas Biotech Ltd share price is INR ₹816.20.
- Windlas Biotech Ltd share price today has been at a low of 806.45 and a high of 835.15. Over the past 52 weeks, the Windlas Biotech Ltd share price has seen a low of 665.10 and a high of 1,178.85.
FAQ’s
What is the share price of Windlas Biotech Ltd today?
Windlas Biotech Ltd share price as on 18 Nov 2025 is ₹ 816.2
What is the Market Cap of Windlas Biotech Ltd?
The market cap of Windlas Biotech Ltd stock is ₹1,747.72 Cr.
What is the PE Ratio of Windlas Biotech Ltd?
The Price to Earnings (P/E) Ratio of Windlas Biotech Ltd is 35.98
What is the PB Ratio of Windlas Biotech Ltd?
The Price to Book (P/B) Ratio of Windlas Biotech Ltd is 4.31
What is the 52 week high of Windlas Biotech Ltd Share Price?
The 52 week high of Windlas Biotech Ltd share price stands at ₹1,178.85
What is the 52 week low of Windlas Biotech Ltd Share Price?
The 52 week low of Windlas Biotech Ltd share price stands at ₹665.10
How can I buy shares of Windlas Biotech Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Windlas Biotech Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
